Results 41 to 50 of about 17,551 (206)

Applications and challenges of glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis

open access: yesLinchuang shenzangbing zazhi, 2022
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis are a diverse group of systemic autoimmune disorders characterized by the presence of ANCA in sera, involving frequently kidney and lung.
Wen Kai-lian, Li Gui-sen, Wang Li
doaj  

ANCA-positive vasculitis: Clinical implications of ANCA types and titers [PDF]

open access: yes, 2016
INTRODUCTION: Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune disease that can affect multiple organs, the kidney being one of the most affected.
Domingues, V., Machado, B., Santos, J.
core   +1 more source

Antineutrophil Cytoplasmic Antibodies and Infection

open access: yesAutoimmunity, 1993
(1993). Antineutrophil Cytoplasmic Antibodies and Infection. Autoimmunity: Vol. 15, No. 1, pp. 81-83.
J M, Durand   +7 more
openaire   +2 more sources

Antineutrophil Cytoplasmic Antibody–Associated Active Scleritis [PDF]

open access: yesArchives of Ophthalmology, 2008
To determine whether antineutrophil cytoplasmic antibody (ANCA) testing provides prognostic information in evaluating scleritis.Retrospective medical record review of patients evaluated at a tertiary care center from January 1, 1995, to June 30, 2006, was performed to compare clinical features, treatments, and associated systemic disease in patients ...
Lani T, Hoang   +4 more
openaire   +2 more sources

Autoantibodies in systemic vasculitis [PDF]

open access: yes, 2015
Systemic vas culitis is a heterogeneous group of disorders characterized by inflammation and necrosis in the vessel wall. the diagnosis of a systemic vasculitis is challenging, because patients usually present a broad spectrum of manifestations that vary
Souza, Alexandre Wagner Silva de
core   +5 more sources

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome [PDF]

open access: yes, 2018
Hydralazine, a vasodilator, is commonly used as an adjunctive treatment for moderate to severe hypertension, heart failure and hypertensive emergencies in pregnancy. Hydralazine-induced lupus was first described in 1953. Clinical presentation ranges from
Aeddula, Narothama Reddy   +3 more
core   +1 more source

Extracellular Vesicle‐Delivered tRF‐His‐GTG‐1 Reprograms Neutrophil Lipophagy and Triggers Inflammation in COVID‐19

open access: yesAdvanced Science, EarlyView.
This study identifies platelet‐derived extracellular vesicles as key immunometabolic regulators in COVID‐19. The delivery of tRF‐His‐GTG‐1 to neutrophils activates TLR8mTOR signaling, disrupts lipophagy, and amplifies NET‐mediated inflammation. Importantly, targeting this axis restores neutrophil homeostasis, offering a potential therapeutic strategy ...
Tsai‐Ling Liao   +5 more
wiley   +1 more source

Medial medullary infarction caused by antineutrophil cytoplasmic antibody-related vasculitis: Case report and review of the literature [PDF]

open access: yes, 2017
Rationale: Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Patient concerns: We report the case of a 76-
Ishii Kazuhiro   +7 more
core   +2 more sources

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

open access: yesAdvanced Science, EarlyView.
This review outlines association between vasculitis and malignancies and provides practical value for clinicians in distinguishing primary vasculitis from malignancy‐associated forms and optimizing patient surveillance, improving recognition of tumor‐associated vasculitis to reduce the risk of misdiagnosis, supporting more accurate clinical decision ...
Xiaofei Shi   +8 more
wiley   +1 more source

Carbimazole-induced agranulocytosis – A rare case report

open access: yesJournal of Dr. NTR University of Health Sciences, 2018
A 30-year-old lady with hyperthyroidism for the past 1 year was initially on carbimazole 30 mg twice orally and then changed to 30 mg once daily.
R Siddeswari, Sikandar Mohan, K Swamy
doaj   +1 more source

Home - About - Disclaimer - Privacy